GT Biopharma, Inc. — Investor Relations & Filings
Filings indexed
862
across all filing types
Latest filing
2026-05-22
Regulatory Filings
Country
US
United States of America
Listing
US
GTBP
GT Biopharma, Inc. is a clinical-stage immuno-oncology company focused on developing innovative therapies based on its proprietary NK cell engager (TriKE®) technology. The TriKE® platform generates therapeutic agents that are designed to simultaneously bind to Natural Killer (NK) cells and cancer cells. This targeted engagement activates and directs the cytotoxic function of NK cells to selectively destroy malignant cells. The company's pipeline targets a range of hematologic malignancies and solid tumors, including acute myeloid leukemia, myeloid dysplastic syndrome, and non-Hodgkin's lymphoma.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-22 | English | |
| 10-Q | 2026-05-15 | English | |
| Regulatory Filings 2026 | 2026-05-14 | English | |
| 424B3 - GT Biopharma, Inc. (0000109657) (Filer) | 2026-05-13 | English | |
| S-1 | 2026-04-30 | English | |
| 8-K - GT Biopharma, Inc. (0000109657) (Filer) | 2026-04-07 | English |
Browse filings by year
32 years- 2026 14 filings
- 2025 53 filings
- 2024 30 filings
- 2023 31 filings
- 2022 41 filings
- 2021 50 filings
- 2020 42 filings
- 2019 36 filings
- 2018 43 filings
- 2017 41 filings
- 2016 27 filings
- 2015 17 filings
- 2014 8 filings
- 2013 2 filings
- 2012 13 filings
- 2011 32 filings
- 2010 23 filings
- 2009 13 filings
- 2008 20 filings
- 2007 42 filings
- 2006 65 filings
- 2005 49 filings
- 2004 42 filings
- 2003 31 filings
- 2002 12 filings
- 2001 7 filings
- 2000 11 filings
- 1999 9 filings
- 1998 16 filings
- 1997 9 filings
- 1996 20 filings
- 1995 13 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 46817358 | 8-K | 2026-05-22 | English | ||
| 46353927 | 10-Q | 2026-05-15 | English | ||
| 46004618 | Regulatory Filings 2026 | 2026-05-14 | English | ||
| 45772480 | 424B3 - GT Biopharma, Inc. (0000109657) (Filer) | 2026-05-13 | English | ||
| 46004609 | S-1 | 2026-04-30 | English | ||
| 33703557 | 8-K - GT Biopharma, Inc. (0000109657) (Filer) | 2026-04-07 | English | ||
| 46004710 | 10-Q/A | 2026-03-06 | English | ||
| 46004763 | 10-Q/A | 2026-03-06 | English | ||
| 32879155 | 10-K - GT BIOPHARMA, INC. (0000109657) (Filer) | 2026-03-02 | English | ||
| 32879154 | 8-K - GT BIOPHARMA, INC. (0000109657) (Filer) | 2026-03-02 | English | ||
| 46004764 | Regulatory Filings 2026 | 2026-02-02 | English | ||
| 17484916 | 424B3 Filing | 2026-01-30 | English | ||
| 17484931 | S-1 Filing | 2026-01-21 | English | ||
| 17484908 | 424B3 Filing | 2026-01-08 | English | ||
|
2025
1 filing
| |||||
| 9203930 | Regulatory Filings 2025 | 2025-12-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
GT Biopharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35496/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35496 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35496 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35496 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35496}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GT Biopharma, Inc. (id: 35496)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.